Suchergebnisse - "Aderka, D"

PubPharm (154)

1

Clinical Characteristics and Prognosis of Gastric Cancer Patients with BRCA 1/2 Germline Mutations: Report of Ten Cases and a Literature Review

in: OncoTargets and Therapy | 2020

von Halpern N | Grinshpun A | Boursi B | +15

2

Consensus molecular subgroups (CMS) of colorectal cancer (CRC) and first-line efficacy of FOLFIRI plus cetuximab or bevacizumab in the FIRE3 (AIO KRK-0306) trial

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2019

von Stintzing, S. | Wirapati, P. | Lenz, H. | +20

3

ESMO consensus guidelines for the management of patients with metastatic colorectal cancer

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2016

von Van Cutsem, E. | Cervantes, A. | Adam, R. | +44

CommentIn: Ann Oncol. 2017 Jan 1;28(1):183. - PMID 27687313

4

P-146Colorectal cancer patients with lung-only metastases have a favorable prognosis irrespective of treatment

enthalten in: Annals of oncology | 2016

von Gadot, M. | Lawrence, Y. | Aderka, D. | +5

5

ESMO consensus guidelines for the management of patients with metastatic colorectal cancer

enthalten in: Annals of oncology | 2016

von Van Cutsem, E. | Cervantes, A. | Adam, R. | +44

6

ESMO consensus guidelines for the management of patients with metastatic colorectal cancer

enthalten in: Annals of oncology | 2016

von Van Cutsem, E. | Cervantes, A. | Adam, R. | +44

7

Overall survival and clinical characteristics of pancreatic cancer in BRCA mutation carriers

enthalten in: British journal of cancer | 2014

von Golan, T. | Kanji, Z. | Epelbaum, R. | +11

8

Overall survival and clinical characteristics of pancreatic cancer in BRCA mutation carriers

enthalten in: The British journal of cancer | 2014

von Golan, T. | Kanji, Z. | Epelbaum, R. | +11

9

Capecitabine and cisplatin with or without cetuximab for patients with previously untreated advanced gastric cancer (EXPAND) : a randomised, open-label phase 3 trial

enthalten in: The Lancet. Oncology | 2013

von Lordick, F. | Kang, Y. | Chung, H. | +114

CommentIn: Lancet Oncol. 2013 May;14(6):440-2. - PMID 23594785

10

Migration Inhibition Factor Activity in Sera of Patients With Chronic Lymphatic Leukemia

enthalten in: Journal of the National Cancer Institute | 2013

von Benjamin, D. | Aderka, D. | Livni, E. | +3

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[16]